Search Results

Genascence Corporation, a clinical-stage biotechnology company revolutionizing the treatment of prevalent musculoskeletal diseases with gene therapy, announced the appointment of Ian Lachlan McLean, M.D., Ph.D. as its chief medical officer.

Chandra Ramanathan, executive-in-residence at Mass General Brigham and a biopharmaceutical executive with extensive experience translating scientific ideas into treatment options and access for patients with high medical needs, has joined McLean Hospital’s Board of Trustees.

Masimo, a leading global provider of medical technology and hospital automation solutions, and Cleveland Clinic, a nonprofit academic medical center, announced the launch of a new partnership centered around hospital-based remote patient monitoring, including TeleCritical Care.

Biotricity Inc. announces a groundbreaking cardiac monitoring pilot program with a prestigious hospital group spanning 9 hospitals and 10 clinics.

GrayMatters Health, a digital therapeutics start-up company, announced that the BIRD Israel-U.S. Binational Industrial Research and Development Foundation awarded a grant to McLean Hospital and the company to develop a novel solution for the therapy of Major Depression Disorder (MDD).

Zai Lab Limited and Innoviva Specialty Therapeutics announced that China’s National Medical Products Administration has approved Zai Lab’s New Drug Application for XACDURO® for the treatment of hospital-acquired bacterial pneumonia and ventilator-associated bacterial pneumonia caused by susceptible isolates of Acinetobacter baumannii-calcoaceticus complex in patients 18 years of age and older.

Daxor Corporation, the global leader in blood volume measurement technology announces the purchase of Daxor’s BVA-100™ at a 450-bed teaching hospital in the greater Chicago area.

RaySearch Laboratories AB is pleased to announce that Raigmore Hospital in Inverness, Scotland has placed an order for the oncology information system RayCare®.